BJDX Company Profile and Key Details
Bluejay Diagnostics, Inc.
BJDX Stock Price Chart
Stock Price Today
Bluejay Diagnostics, Inc. (BJDX) stock surged +1.40%, trading at $3.62 on NASDAQ, up from the previous close of $3.57. The stock opened at $3.59, fluctuating between $3.51 and $3.63 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Company Information
| Employees | 10 |
| Beta | 0.73 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) stock price is $3.62 in the last trading session. During the trading session, BJDX stock reached the peak price of $3.63 while $3.51 was the lowest point it dropped to. The percentage change in BJDX stock occurred in the recent session was 1.4% while the dollar amount for the price change in BJDX stock was $0.05.
The NASDAQ listed BJDX is part of Medical - Devices industry that operates in the broader Healthcare sector. Bluejay Diagnostics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Eryn Graham
Marketing Mang.
Mr. Indranil Dey
Pres, Chief Executive Officer & Director
Mr. Kevin Vance
Chief Commercial Officer
Dr. Mark W. Feinberg M.D.
Chief Medical Advisor
Mark W. Feinberg
Chief Medical Advisor
Dr. Jason Cook
Chief Technology Officer
Mr. Kenneth R. Fisher CPA
Chief Financial Officer
Ryan McSeveney
Corporation Controller
Mr. Les DeLuca
Vice President of Operations
BJDX's closing price is 19.47% higher than its 52-week low of $3.03 where as its distance from 52-week high of $386.80 is -99.06%.
Number of BJDX employees currently stands at 10.
Official Website of BJDX is: https://www.bluejaydx.com
BJDX could be contacted at phone 844 327 7078 and can also be accessed through its website. BJDX operates from 360 Massachusetts Avenue, Acton, MA 01720, United States.
BJDX stock volume for the day was 7.44K shares. The average number of BJDX shares traded daily for last 3 months was 690.18K.
The market value of BJDX currently stands at $2.00M with its latest stock price at $3.62 and 552.85K of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com